Scripps Research-led consortium awarded $129 million from NIH for new HIV vaccine approach

IMAGE: This computer-generated graphic depicts immune system proteins called broadly neutralizing antibodies (bnAbs; colored) binding to different regions on the HIV envelope protein on the surface of the virus (white). Antibody… view more  Credit: Scripps Research LA JOLLA, Calif. — The Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), an international collaboration led by Scripps Research, has…

Details